EURAMOS-1, an international randomised study for osteosarcoma: Results from pre-randomisation treatment

J. S. Whelan, S. S. Bielack, N. Marina, S. Smeland, G. Jovic, J. M. Hook, M. Krailo, J. Anninga, T. Butterfass-Bahloul, Tom Böhling, G. Calaminus, M. Capra, C. Deffenbaugh, C. Dhooge, M. Eriksson, A. M. Flanagan, H. Gelderblom, A. Goorin, R. Gorlick, G. GoshegerR. J. Grimer, K. S. Hall, K. Helmke, P. C.W. Hogendoorn, G. Jundt, L. Kager, T. Kuehne, C. C. Lau, G. D. Letson, J. Meyer, P. A. Meyers, C. Morris, H. Mottl, H. Nadel, R. Nagarajan, R. L. Randall, P. Schomberg, R. Schwarz, L. A. Teot, Matthew R. Sydes, M. Bernstein, James Pickering, Nicola Joffe, Matthias Kevric, Benjamin Sorg, Doojduen Villaluna, Caroline Wang, Martha Perisoglou, Leonardo Trani, Jenny Potratz, Dorothe Carrle, Miriam Wilhelm, Katja Zils, Carmen Teske

Research output: Contribution to journalArticlepeer-review

216 Scopus citations


This manuscript describes the experience from registration until randomisation for a cohort of 2260 patients with osteosarcoma who joined the EURAMOS-1 trial. This includes pre-operative chemotherapy and surgery. It sets out the practical issues in collaboration and in achieving randomisation.

Original languageEnglish (US)
Pages (from-to)407-414
Number of pages8
JournalAnnals of Oncology
Issue number2
StatePublished - Feb 1 2015


  • International collaboration
  • Osteosarcoma
  • Randomised controlled trial
  • Trial conduct

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'EURAMOS-1, an international randomised study for osteosarcoma: Results from pre-randomisation treatment'. Together they form a unique fingerprint.

Cite this